Showing results (61-70 of 67) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Blood|September 20, 2002
Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody productionMee Rhan Kim, Raffi Manoukian, Richard Yeh, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 5, 2011
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bonesMichael S Ominsky, Chaoyang Li, Xiaodong Li, et al.Regulatory Toxicology and Pharmacology : RTP|June 27, 2020
Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fractureJames R Turk, Aimee M Deaton, Jun Yin, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 14, 2008
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strengthXiaodong Li, Michael S Ominsky, Qing-Tian Niu, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2008
Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKLPaul J Kostenuik, Hung Q Nguyen, James McCabe, et al.Nature Communications|May 28, 2016
A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repairMonica Florio, Kannan Gunasekaran, Marina Stolina, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 21, 2011
Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injuryXiaodong Li, Mario Grisanti, Wei Fan, et al.Pageof 7